title: [Tonsillar and oral cancer should be considered in the discussion on HPV vaccine].
authors.forename: Gunilla
authors.initials: G
authors.lastname: Andersson
authors.forename: Bengt Göran
authors.initials: BG
authors.lastname: Hasson
authors.forename: Kerstin
authors.initials: K
authors.lastname: Rosenquist
authors.forename: Elsy-Britt
authors.initials: EB
authors.lastname: Schildt
authors.forename: Johan
authors.initials: J
authors.lastname: Wennerberg
mesh_terms: D052162:Human papillomavirus 16; D006801:Humans; D009062:Mouth Neoplasms / Q000517:prevention & control / Q000821:virology*; D030361:Papillomavirus Infections / Q000517:prevention & control / Q000821:virology*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D012307:Risk Factors; D014067:Tonsillar Neoplasms / Q000517:prevention & control / Q000821:virology*
chemical_list: D053918:Papillomavirus Vaccines